ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bristol Myers Squibb Receives European Commission Approval of Zeposia for Ulcerative Colitis
December 01, 2021Bristol Myers Squibb today announced that the European Commission has granted a Marketing Authorization for Zeposia (ozanimod) for the treatment of adults with moderately to severely active ulcerative colitis (UC) who have had an inadequate response... -
EC approve Zeposia® to treat ulcerative colitis
November 29, 2021The European Commission (EC) has has granted a marketing authorisation for Zeposia® (ozanimod) for the treatment of adults with moderately to severely active ulcerative colitis (UC)... -
Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel S1P Receptor Modulator
March 12, 2019Bridge Medicines announced an agreement with Weill Cornell Medicine to develop a novel sphingosine 1-phosphate (S1P) receptor modulator.
Pharma Sources Insight January 2025
